International TRPM3 Disorder Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

TRPM3Care is an international, multicenter observational registry designed to collect standardized clinical, genetic, imaging, electrophysiological, and longitudinal outcome data from individuals with TRPM3-associated disorders. The study aims to describe natural history, understand genotype-phenotype relationships, and support future therapeutic research. Data are gathered from participating centers to enable comparisons of disease progression and response to therapies, as well as impact on daily living. Participation requires informed consent and a confirmed TRPM3 variant. This is not a treatment trial; it observes patients to inform future studies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Variant in the TRPM3 gene

Exclusion Criteria:

* no consent from patient/familiy

Where it's running

• Charité- Universitätsmedizin Berlin- Neuropediatrics
  Berlin, State of Berlin, Germany Recruiting

Study contacts

• Principal investigator: Lena-Luise Becker, Dr. med. — Charité- Universitätsmeidzin Berlin- Neuropediatrics
• Study coordinator: Lena-Luise Becker, Dr. med.
• Email: lena-luise.becker@charite.de
• Phone: 0049 03 450 566 122

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How to talk about vaccines: does different communication help people decide to get vaccinated?

  This online randomized trial tests whether specific communication formats can improve knowledge and willingness to get vaccinated for TBE (Germany) or yellow fever (Colombia).

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07921121

• AI-generated treatment recommendations for precision oncology

  A non-interventional study tests whether AI-generated treatment options for advanced solid tumors align with what doctors would personally recommend.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT07897110

• DHEA add-on to standard antidepressants for treatment-resistant depression

  This trial tests whether adding 100 mg/day of DHEA to patients’ current antidepressant treatment helps people with treatment-resistant depression feel better.

  Recruiting at 9 sites Phase 3 Charite University, Berlin, Germany · Berlin, State of Berlin and 8 other locations · NCT07843927

• Context-adapted quality indicators for early sepsis care in Sub-Saharan Africa

  A group of sepsis experts in Sub-Saharan Africa will participate in a series of online surveys and feedback meetings to agree on practical quality indicators for early sepsis care.

  Recruiting Charite University, Berlin, Germany · Kumasi · NCT07711535

• TNPO2-related disorders registry

  This international registry tests how TNPO2 gene variants relate to neurodevelopmental issues by collecting medical, genetic, and developmental data from people with pathogenic TNPO2 variants.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07699510

• High-fiber diet with short-term fasting during melanoma immunotherapy

  This study tests whether a high-fiber diet, with or without short-term fasting, can help people with melanoma better tolerate and respond to immune checkpoint inhibitors.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07680452

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.